Medical Weight Loss in San Francisco

Medical Weight Loss in San Francisco

Weight loss is a difficult journey for many. With 1 in 10 adults obese in America, we know how hard it can be to find an approach that actually works for your body. Medical weight loss injections, including Semaglutide (Wegovy/Ozempic) and Mounjaro, can be the right answer for many San Francisco patients, but lasting results come from pairing the medication with lab testing that addresses what’s really driving the weight gain — hormonal imbalances, metabolic resistance, or insulin sensitivity.

Targeting Stubborn Belly Fat & Metabolic Resistance

Many of our patients struggle with stubborn visceral (belly) fat that resists traditional diet and exercise. Our medical weight loss protocols are specifically designed to address the root hormonal causes of midsection weight gain, utilizing targeted metabolic therapies to reset your body’s fat-burning capabilities.

Sign Up to Receive our Comprehensive Hormone Questionnaire to Find Out Your Imbalances

By submitting this form, you are consenting to receive marketing emails from: Radiant Health SF, 2400 las gallinas Ave. San Rafael. Ca. 94903, https://radianthealthsf.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. 

GLP-1 Weight Loss Program

Our physician-guided GLP-1 program combines evidence-based medication with ongoing lifestyle support, built around your labs and your goals.

Mounjaro Injections

Mounjaro (tirzepatide) targets two hormone receptors at once, with results that have outperformed other GLP-1 medications in clinical studies.

Zepbound Injections

Zepbound brings the same tirzepatide science to patients looking for an FDA-approved option tailored to their treatment history.

HCG Weight Loss Program

For patients who prefer a non-injectable hormone protocol, our HCG program pairs a structured nutrition plan with physician supervision to reset metabolism.

How Semaglutide Works

Semaglutide regulates appetite and blood sugar through the same GLP-1 pathway used by other weight loss medications, with once-weekly injections and FDA approval for long-term weight management.